Current Opinion in Neurology

Article	Citations
Update on management of cerebral venous thrombosis	78
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	61
Management of neuropsychiatric symptoms in dementia	52
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	49
The recent surge of functional movement disorders: social distress or greater awareness?	48
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	46
The role of the gut microbiome in Alzheimer's disease pathophysiology	42
Editorial introductions	40
Microglia in multiple sclerosis – pathogenesis and imaging	39
Central nervous system adverse events of immune checkpoint inhibitors	33
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	33
Historical development and contemporary use of neuromodulation in human spinal cord injury	29
Hereditary motor neuropathies	29
Neurology education in the era of artificial intelligence	29
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	29
Gene therapies for CMT neuropathies: from the bench to the clinic	27
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	26
From basic mechanisms to therapeutic perspectives in cluster headache	25
Editorial introductions	24
Multiple sclerosis in China: the current state of diagnosis and management	22
Updates in neuro-otology	21
Editorial: Epilepsy advances in 2023	21
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	21
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	21
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	21

Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	20
Connecting tremors – a circuits perspective	20
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	20
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	20
Migraine in women: a review	20
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	20
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	19
Threat of resurgence or hope for global eradication of poliovirus?	19
Thymectomy in myasthenia gravis	19
Nerve ultrasound in the diagnosis of inflammatory neuropathies	19
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	18
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	18
Clinical impact of molecular profiling in rare brain tumors	18
Acute stroke care in low and middle-income countries	17
Red flags in multiple sclerosis	17
Levodopa infusion therapies for Parkinson disease	17
Gauging and controlling excitability in cortical disorders	17
The FSHD jigsaw: are we placing the tiles in the right position?	17
Electrical stimulation of the peripheral and central vestibular system	16
MRI for the diagnosis of limb girdle muscular dystrophies	16
Diet and migraine: what is proven?	16
fMRI-based spatio-temporal parcellations of the human brain	16
Editorial: Advances in neuro-oncology: stepping in the right direction	16
Parkinson's disease – genetic cause	16
Obesity-related neuropathy: the new epidemic	16
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	15
Neurosyphilis in 2025	15
Recent advances in Alzheimer disease genetics	15
Update on dermatomyositis	15
Neuroinflammation and immunometabolism in neurodegenerative diseases	15
Idiopathic intracranial hypertension: expanding our understanding	15
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	14
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	14
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	14
Progress in spinal muscular atrophy research	14
Targeting IDH1/IDH2 mutations in gliomas	14
Novel approaches to treatment of leptomeningeal metastases	14
Editorial: The gap between academic advances and therapy development in motor neuron disease	14
Optic neuritis: current challenges in diagnosis and management	14
Diagnosing viral encephalitis and emerging concepts	13
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	13
Monitoring multiple sclerosis: digital and fluid phase biomarkers	13
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	13
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	13
Current trend in air pollution exposure and stroke	13
Visually induced dizziness	13
Recent insights in striated muscle laminopathies	13
New developments in diagnostics and treatment of adult-onset focal dystonia	13
Sex and gender differences in neurological infections	13
The state of art on the use of patient reported outcomes in migraine	13

Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	12
Fluid phase biomarkers in multiple sclerosis	12
Abnormal energy metabolism in ALS: a key player?	12
Update on genetics of amyotrophic lateral sclerosis	12
New insights in the immune treatment of Guillain–Barré syndrome	12
Advanced neuroimaging techniques in epilepsy	12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	12
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	11
Update on modifiable risk factors for Alzheimer's disease and related dementias	11
Imaging cortical lesions in multiple sclerosis	11
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	11
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	10
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	10
Pharmacotherapy of cerebellar and vestibular disorders	10
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	10
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	10
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	10
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	10
Peripheral visual field loss and activities of daily living	10
Current gaps in acute reperfusion therapies	10
Editorial: Seizure disorders: 2023 update	10
Editorial: Making the invisible visible: updates on vestibular neurology	10
Interrogating large multiple sclerosis registries and databases: what information can be gained?	9
Multiple sclerosis: advances and challenges in diagnosis	9
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	9
Therapeutic thoroughfares for adults living with Pompe disease	9
Progress in treatment of gliomas	9
Editorial: Cerebrovascular disease	9
Nonneurologic causes of binocular diplopia for the neurologist	9
An update on psychogenic nonepileptic seizures	9
Long COVID and especially headache syndromes	9
Progression in multiple sclerosis – a long-term problem	9
Ménière's disease: new guidelines, subtypes, imaging, and more	9
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	9
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	9
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	9
Muscle ultrasound in myopathies	9
Motion sickness: current concepts and management	9
Perception and control of a virtual body in immersive virtual reality for rehabilitation	9
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	9
Editorial introductions	9
Editorial: Advances in brain tumors management: new perspectives and challenges	8
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	8
Combined neuromodulatory approaches in the central nervous system for treatment of spinal cord injury	8
Neuro-infectious disorders – reasons to be cheerful but it is a long and winding road	8
Emerging concepts and therapies for amyotrophic lateral sclerosis	8
Editorial:Framing artificial intelligence to neuromuscular disorders	8
Editorial improving movement disorders healthcare across the globe	8
Editorial introductions	8
Barriers to clinical genetic testing in movement disorders	8
Editorial introductions	8
Atypical forms of Alzheimer's disease: patients not to forget	8
Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined	8
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	8
New targets in spontaneous intracerebral hemorrhage	8
The current landscape of epilepsy genetics: where are we, and where are we going?	8
Shifting our attention earlier in the multiple sclerosis disease course	7
Vestibular and auditory manifestations of migraine	7
Endogenous clues promoting remyelination in multiple sclerosis	7
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	7
Lesion network mapping for symptom localization: recent developments and future directions	7
Editorial: Advances in stroke management and upcoming challenges	7
Headache in infections	7
Socioeconomic disparities in epilepsy care	7
PET-based brain molecular connectivity in neurodegenerative disease	7
Targeting gene fusions in glioma	7
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	7
Rescue therapies in epilepsy	7
Imaging and neuromodulation in Parkinson's disease	7
Editorial introductions	6
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	6
The genetics of amyotrophic lateral sclerosis	6
Autoimmune neuromyotonia	6
Congenital myasthenic syndromes: increasingly complex	6
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	6
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	6
The role of caffeine in headache disorders	6
Brain health in HIV: pathogenesis, classification, and treatment	6
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	6
Editorial: Current opinions in neurology editorial	6

Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	6
Recent insights into haematology and peripheral nerve disease	6
Editorial introductions	6
Medical and neurologic management of brain tumor patients	5
An update on multiple system atrophy	5
Leprous neuropathy	5
Recent advances in epilepsy surgery	5
Recent developments in multiple sclerosis neuropathology	5
Current concepts in acute vestibular syndrome and video-oculography	5
Novel pathophysiological insights in autoimmune myasthenia gravis	5
Emerging neuroinfectious diseases: public health implications	5
Recent advances in the genetics of Parkinson's disease in underrepresented populations	5
Editorial introductions	5
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	5
Autoimmune nodopathies, an emerging diagnostic category	5
Persistent aura without infarction	5
Ambulatory seizure detection	5
Editorial: Update on movement disorders	5
Update on myelin imaging in neurological syndromes	5
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	5
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	5
Current understanding of skeletal muscle repeat expansion disorders	5
Spasticity following brain and spinal cord injury: assessment and treatment	5
Promoting exogenous repair in multiple sclerosis: myelin regeneration	4
Defining the presymptomatic phase of frontotemporal dementia	4
The current clinical perception of myotonic dystrophy type 2	4
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	4
Advances in myopathy research: promising developments and challenges	4
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	4
Recent advances, challenges and perspectives in cerebrovascular disease	4
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	4
Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury	4
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data	4
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	4
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	4
The evolving spectrum of complex inherited neuropathies	4
Current drug treatment of myasthenia gravis	4
Systemic vasculitis and headache	4
Immunology of multiple sclerosis: an update	4
Late-onset myopathies	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	4
Somatic mosaicism in focal epilepsies	4
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	4
Novel trial designs in neuro-oncology	4
Spinal cord pathology revealed by MRI in traumatic spinal cord injury	4
Vestibular syncope	4
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration	4
Intravenous thrombolysis for acute ischemic stroke: why not?	4
Editorial introductions	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	4